MONECO ADVISORS, LLC

Position in EXEL — Exelixis, Inc.

CIK 1765690 FAIRFIELD, CT

Position in EXEL

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$334,893

+$73,093 QoQ

Shares Held

6,155

+0.8% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#500

of 751 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

MONECO ADVISORS, LLC holds $2,660,345 across 4 Biotechnology names. EXEL ranks #2 (12.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	7,472	$1,828,921
2	EXEL	Exelixis, Inc. This page	6,155	$334,893
3	JAZZ	Jazz Pharmaceuticals plc	1,177	$283,621
4	DNLI	Denali Therapeutics Inc.	8,278	$212,910

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$334,893	6,155	+0.8%	Shares	Sole	2026-08-11
2026-03-31	$261,800	6,104	-0.6%	Shares	Sole	2026-05-08
2025-12-31	$269,028	6,138	-0.1%	Shares	Sole	2026-02-04
2025-09-30	$253,829	6,146	+25.0%	Shares	Sole	2025-11-05
2025-06-30	$216,785	4,918	—	Shares	Sole	2025-08-13
No filing history on record for this holder in this stock.